Evidence map›Paper›PMID 41486519›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Redox Oligomer Assembling Hierarchical Reinforced Framework Cathodes for Ultra-Stable High-Performance Zinc-Ion Batteries.

Shuang Liu, Yiliang Lai, Yinghang Gao, Weihua Tang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuang LiuCollege of Materials, College of Chemistry and Chemical Engineering, Innovation Laboratory of Energy Materials of Fujian Province (IKKEM), Xiamen University, Xiamen, Fujian, China.
Yiliang LaiCollege of Materials, College of Chemistry and Chemical Engineering, Innovation Laboratory of Energy Materials of Fujian Province (IKKEM), Xiamen University, Xiamen, Fujian, China.
Yinghang GaoCollege of Energy, Xiamen University, Xiamen, Fujian, China.
Weihua TangCollege of Materials, College of Chemistry and Chemical Engineering, Innovation Laboratory of Energy Materials of Fujian Province (IKKEM), Xiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0002-7539-9322

Funding

National Natural Science Foundation of China 21875111National Natural Science Foundation of China 22375170Plans for the Recruitment of Top-notch Talent by Fujian Province and Xiamen cityTan Kah Kee Innovation Laboratory HRTP-[2022]-45
6 · The paper itself

Abstract

Organic cathodes with maximal redox active-sites and structural tunability are in great demand for aqueous zinc-ion batteries (ZIBs). Currently, they are facing challenges of limited capacity, poor cycling stability, and sluggish ion transport in practical applications. In this work, we have developed a universal and efficient strategy to assemble a redox oligomer into a conductive substrate imitating a reinforced concrete framework as freestanding cathodes for high-performance ultrastable ZIBs. The signature molecule was specifically designed by sandwiching phenoxoline with two benzoquinone units to explore the most redox-active sites. 2D MXene nanosheets convalently bonded with single-walled carbon nanotubes to construct hierachical reinforced framework with superior porosity and structural rigidity. Benefiting from superior structural robustness and electrochemical dynamics, the cathodes deliver the highest specific capacity of 339.5 mAh g

Indexed as

aqueous zinc‐ion batteryenergy storagehierachical nanostructureorganic cathodereinforced concrete framework

Identifiers

PMID41486519
PMCPMC12970184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.